Fig. 4From: Efficacy and safety of baricitinib in Japanese patients with autoinflammatory type I interferonopathies (NNS/CANDLE, SAVI, And AGS)PGA scores in patients with (A) NNS/CANDLE, (B) SAVI, and (C) AGS. AGS = Aicardi-Goutières syndrome; NNS/CANDLE = Nakajo-Nishimura syndrome/chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature; SAVI = STING-associated vasculopathy with onset during infancy; STING = stimulator of interferon genesBack to article page